Understanding when and how physicians dispense product samples
Because physicians' use of product samples varies across pharmaceutical classes and products in measurable ways, it behooves drug companies to start assessing how much their sampling is actually boosting market share and how much it is simply cutting their revenue-generating prescriptions.
You may also be interested in...
What percentage of samples dispensed support their major purpose--encouraging new courses of prescription therapy? The unsettling answer: far more than most people think.
The European Medicines Agency has reported progress with a collaborative project that involves other regulators in its assessments of COVID-19 products, and with the EU Medicines for All initiative for evaluating products for non-EU markets.